Assignee
EYEBIO KOREA
KR·4 granted patents·1 pending application·4 citations·filing 2015–2024
Top patents by PatentIndex Score
5 records- 0182US10532084B2Chondrocyte extracellular matrix-derived peptideEYEBIO KOREA·Filed 2018·Granted Jan 14, 2020·4 cites·6 claims
- 0280US2024352071A1Novel Peptide Compound Or Pharmaceutically Acceptable Salt ThereofEYEBIO KOREA·Filed 2024·Application pending·0 cites
- 0370US12428446B2Peptide compound or pharmaceutically acceptable salt thereofEYEBIO KOREA·Filed 2020·Granted Sep 30, 2025·0 cites·5 claims
- 0461US10709768B2Chondrocyte extracellular matrix-derived peptideEYEBIO KOREA·Filed 2017·Granted Jul 14, 2020·0 cites·11 claims
- 0545US10913788B2Pharmaceutical composition for preventing or treating dry eyesEYEBIO KOREA·Filed 2015·Granted Feb 9, 2021·0 cites·6 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →